← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 29, 2020Last known activity
Feb 29, 2020
Acquired by Ultragenyx Inc. on Jul 25, 2022
Timeline
2010s
- Dec 1, 2017
GeneTX Biotherapeutics, LLC— Founded
2020s
- Jul 25, 2022
Ultragenyx Inc.— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04259281Lead sponsorPhase 1/Phase 2Feb 29, 2020
Details
- Founded
- Sarasota, FL, US Dec 1, 2017
- Last known activity
- Feb 29, 2020